112 related articles for article (PubMed ID: 10319761)
21. The preparation and biological characterization of a new HL91-derivative for hypoxic imaging on stroke mice.
Hsia CC; Huang FL; Lin CH; Shen LH; Wang HE
Appl Radiat Isot; 2010 Sep; 68(9):1610-5. PubMed ID: 20395152
[TBL] [Abstract][Full Text] [Related]
22. 99mTc-HL91: "hot spot" detection of ischemic myocardium in vivo by gamma camera imaging.
Okada RD; Johnson G; Nguyen KN; Liu Z; Edwards B; Archer CM; North TL; King AC; Kelly JD
Circulation; 1998 Jun; 97(25):2557-66. PubMed ID: 9657477
[TBL] [Abstract][Full Text] [Related]
23. Increased uptake of 99mTc-HL91 in tumor cells exposed to X-ray radiation.
Kinuya S; Yokoyama K; Konishi S; Li XF; Watanabe N; Shuke N; Aburano T; Takayama T; Michigishi T; Tonami N
Ann Nucl Med; 2000 Apr; 14(2):139-41. PubMed ID: 10830534
[TBL] [Abstract][Full Text] [Related]
24. Serial hypoxia imaging with 99mTc-HL91 SPECT to predict radiotherapy response in nonsmall cell lung cancer.
Li L; Yu J; Xing L; Ma K; Zhu H; Guo H; Sun X; Li J; Yang G; Li W; Yue J; Li B
Am J Clin Oncol; 2006 Dec; 29(6):628-33. PubMed ID: 17149002
[TBL] [Abstract][Full Text] [Related]
25. Intratumoral distribution of tritiated-FDG in breast carcinoma: correlation between Glut-1 expression and FDG uptake.
Brown RS; Leung JY; Fisher SJ; Frey KA; Ethier SP; Wahl RL
J Nucl Med; 1996 Jun; 37(6):1042-7. PubMed ID: 8683298
[TBL] [Abstract][Full Text] [Related]
26. 99mTc-HL91 is inferior to 201Tl in scintigraphic detection of chronic myocardial ischaemia.
Wu YW; Lee CM; Huang YH; Chou NK; Yen RF; Tzen KY; Huang PJ
Nucl Med Commun; 2005 Dec; 26(12):1119-23. PubMed ID: 16264360
[TBL] [Abstract][Full Text] [Related]
27. [Clinical application of 99mTc-HL91 hypoxia imaging in nasopharyngeal carcinoma].
Zheng YJ; Fan W; Zhao C; Yang XC; Cui NJ; Chen FJ
Ai Zheng; 2006 Mar; 25(3):378-81. PubMed ID: 16536999
[TBL] [Abstract][Full Text] [Related]
28. Dissociation of glucose tracer uptake and glucose transporter distribution in the regionally ischaemic isolated rat heart: application of a new autoradiographic technique.
Southworth R; Dearling JL; Medina RA; Flynn AA; Pedley RB; Garlick PB
Eur J Nucl Med Mol Imaging; 2002 Oct; 29(10):1334-41. PubMed ID: 12271416
[TBL] [Abstract][Full Text] [Related]
29. 99mTc-Hynic-annexin V imaging to evaluate inflammation and apoptosis in rats with autoimmune myocarditis.
Tokita N; Hasegawa S; Maruyama K; Izumi T; Blankenberg FG; Tait JF; Strauss HW; Nishimura T
Eur J Nucl Med Mol Imaging; 2003 Feb; 30(2):232-8. PubMed ID: 12552341
[TBL] [Abstract][Full Text] [Related]
30. Microautoradiographic study for the differentiation of intratumoral macrophages, granulation tissues and cancer cells by the dynamics of fluorine-18-fluorodeoxyglucose uptake.
Kubota R; Kubota K; Yamada S; Tada M; Ido T; Tamahashi N
J Nucl Med; 1994 Jan; 35(1):104-12. PubMed ID: 8271030
[TBL] [Abstract][Full Text] [Related]
31. Autoradiography and radioscintigraphy of technetium-99m-sestamibi in c-neu transgenic mice.
Crane PD; Onthank DC; Bourque CR; Heminway SJ; Mazaika TJ; Leav I; Zambuto GF; Lazewatsky JL; Villamil-Perez L; Carroll TR
J Nucl Med; 1995 Oct; 36(10):1862-8. PubMed ID: 7562056
[TBL] [Abstract][Full Text] [Related]
32. Anti-angiogenic therapy and chemotherapy affect 99mTc sestamibi and 99mTc-HL91 accumulation differently in tumour xenografts.
Kinuya S; Yokoyama K; Fukuoka M; Mori H; Shiba K; Watanabe N; Shuke N; Michigishi T; Tonami N
Nucl Med Commun; 2005 Dec; 26(12):1067-73. PubMed ID: 16264352
[TBL] [Abstract][Full Text] [Related]
33. Intratumoral distribution of tritiated fluorodeoxyglucose in breast carcinoma: I. Are inflammatory cells important?
Brown RS; Leung JY; Fisher SJ; Frey KA; Ethier SP; Wahl RL
J Nucl Med; 1995 Oct; 36(10):1854-61. PubMed ID: 7562055
[TBL] [Abstract][Full Text] [Related]
34. Comparison of the distribution of fluorine-18 fluoromisonidazole, deoxyglucose and methionine in tumour tissue.
Kubota K; Tada M; Yamada S; Hori K; Saito S; Iwata R; Sato K; Fukuda H; Ido T
Eur J Nucl Med; 1999 Jul; 26(7):750-7. PubMed ID: 10398823
[TBL] [Abstract][Full Text] [Related]
35. In vitro and in vivo evaluation of a technetium-99m-labeled 2-nitroimidazole (BMS181321) as a marker of tumor hypoxia.
Ballinger JR; Kee JW; Rauth AM
J Nucl Med; 1996 Jun; 37(6):1023-31. PubMed ID: 8683295
[TBL] [Abstract][Full Text] [Related]
36. Methionine uptake by tumor tissue: a microautoradiographic comparison with FDG.
Kubota R; Kubota K; Yamada S; Tada M; Takahashi T; Iwata R; Tamahashi N
J Nucl Med; 1995 Mar; 36(3):484-92. PubMed ID: 7884515
[TBL] [Abstract][Full Text] [Related]
37. Marking hypoxia in rat prostate carcinomas with beta-D-[125I]azomycin galactopyranoside and.
Iyer RV; Haynes PT; Schneider RF; Movsas B; Chapman JD
J Nucl Med; 2001 Feb; 42(2):337-44. PubMed ID: 11216534
[TBL] [Abstract][Full Text] [Related]
38. Pharmacokinetics of [18F]FETNIM: a potential marker for PET.
Grönroos T; Eskola O; Lehtiö K; Minn H; Marjamäki P; Bergman J; Haaparanta M; Forsback S; Solin O
J Nucl Med; 2001 Sep; 42(9):1397-404. PubMed ID: 11535732
[TBL] [Abstract][Full Text] [Related]
39. Evaluation of 64Cu-ATSM in vitro and in vivo in a hypoxic tumor model.
Lewis JS; McCarthy DW; McCarthy TJ; Fujibayashi Y; Welch MJ
J Nucl Med; 1999 Jan; 40(1):177-83. PubMed ID: 9935074
[TBL] [Abstract][Full Text] [Related]
40. Assessment of cancer recurrence in residual tumors after fractionated radiotherapy: a comparison of fluorodeoxyglucose, L-methionine and thymidine.
Reinhardt MJ; Kubota K; Yamada S; Iwata R; Yaegashi H
J Nucl Med; 1997 Feb; 38(2):280-7. PubMed ID: 9025756
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
